CompletedInterventionalNot ApplicableUpdated Jun 19, 2018
Clinical Comparison of Silicone Hydrogel and HEMA-based Daily Disposable Contact Lenses | NCT01362907 | Trialant
CompletedInterventionalNot ApplicableUpdated Aug 3, 2012
Clinical Comparison of Silicone Hydrogel and HEMA-based Daily Disposable Contact Lenses
ClinicalTrials.gov ID
NCT01362907
Lead Sponsor
CIBA VISIONINDUSTRY
Overall Status
Completed
Study Type
Interventional
Phase
Not Applicable
Enrollment
40Actual
Last Update Posted
Aug 3, 2012Estimated
Start Date
May 2011
Primary Completion Date
Jun 2011Actual
Completion Date
Jun 2011Actual
Brief Summary
The purpose of this trial was to compare the performance of an investigational daily disposable contact lens to a commercially available daily disposable contact lens.
Myopia
Delefilcon A contact lens
Etafilcon A contact lens
Ages Eligible for Study
Child (0-17)Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Normal eyes with no use of ocular medications.
Be of legal age of consent and sign Informed Consent document. If under legal age of consent, legally authorized representative must sign Informed Consent document and subject must sign Assent document.
Willing and able to wear spherical contact lenses for protocol-specified timeframe within the available range of powers (-1.00 D to -6.00D in 0.25D steps).
Visual acuity with study lenses 20/25 or better.
Cylinder less than or equal to 0.75 D.
Currently wearing daily disposable lenses.
Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
Anterior segment infection, inflammation, or abnormality.
Any active anterior segment ocular disease that would contraindicate contact lens wear.
Any use of systemic medications for which contact lens wear could be contraindicated as determined by the investigator.
History of refractive surgery or irregular cornea.
Eye injury within twelve weeks immediately prior to enrollment for this trial.
Currently enrolled in any clinical trial.
Other protocol-defined exclusion criteria may apply.